| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sara Salama, Majid Khan, Michael Levy, Izlem Izbuda. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease. Multiple sclerosis and related disorders. vol 29. 2019-07-16. PMID:30658259. |
mog antibody disease is an autoimmune disease of the central nervous system (cns) characterized by the presence of a serological antibody against myelin oligodendrocyte glycoprotein (mog). |
2019-07-16 |
2023-08-13 |
Not clear |
| Xinguang Yang, Qingmei Huang, Huacai Yang, Si Liu, Baikeng Chen, Tianni Liu, Jie Yang, Haiyan Yao, Shaopeng Lin, Xiaohui Chen, Honghua Zhuang, Youming Long, Cong Ga. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack. Multiple sclerosis and related disorders. vol 29. 2019-07-16. PMID:30690341. |
determination of glial fibrillary acidic protein (gfap), aquaporin 4 (aqp4), and myelin oligodendrocyte glycoprotein (mog) levels in cerebrospinal fluid (csf), and astrocytic damage analysis in patients with gfap astrocytopathy (gfap-a) and other conditions. |
2019-07-16 |
2023-08-13 |
Not clear |
| Michael L Lehmann, Thaddeus K Weigel, Abdel G Elkahloun, Miles Herkenha. Chronic social defeat reduces myelination in the mouse medial prefrontal cortex. Scientific reports. vol 7. 2019-07-15. PMID:28418035. |
the down regulation was confirmed by in situ hybridization histochemistry for two strongly down-regulated genes, myelin oligodendrocyte glycoprotein (mog) and ermin (ermn), and by immunohistochemistry for myelin basic protein. |
2019-07-15 |
2023-08-13 |
mouse |
| Mehrdad Gholamzad, Masoumeh Ebtekar, Mehdi Shafiee Ardestan. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis. Iranian journal of allergy, asthma, and immunology. vol 16. issue 3. 2019-07-09. PMID:28732440. |
the myelin oligodendrocyte glycoprotein (mog) peptide and ovalbumin peptide(ova) were covalently bound to the synthetic plga nanoparticles in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (edci) and were injected to six groups of c57bl/6 mice one week before the induction of the experimental autoimmune encephalomyelitis (eae) intravenously or subcutaneously; one group was considered as control; finally, immunologic responses including delayed-type hypersensitivity (dth) response and lymphocyte proliferation were investigated. |
2019-07-09 |
2023-08-13 |
mouse |
| Sudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, Tina Kim Nguyen, Vera Merheb, Victor S C Fung, Owen Bruce White, Simon Broadley, Jeannette Lechner-Scott, Steve Vucic, Andrew P D Henderson, Michael Harry Barnett, Stephen W Reddel, Fabienne Brilot, Russell C Dal. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. Journal of neurology, neurosurgery, and psychiatry. vol 89. issue 2. 2019-07-08. PMID:29142145. |
we characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (mog) antibody-associated demyelination. |
2019-07-08 |
2023-08-13 |
Not clear |
| Shervin Bahrami, Elzbieta Anna Gryz, Jonas Heilskov Graversen, Anne Troldborg, Kristian Stengaard Pedersen, Magdalena Janina Lask. Immunomodulating peptides derived from different human endogenous retroviruses (HERVs) show dissimilar impact on pathogenesis of a multiple sclerosis animal disease model. Clinical immunology (Orlando, Fla.). vol 191. 2019-07-05. PMID:29567431. |
in this report, we demonstrate that env59-gp3 peptide holds therapeutic potential in a mouse model of myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae). |
2019-07-05 |
2023-08-13 |
mouse |
| Yong Chan Kim, Ai-Hong Zhang, Jeongheon Yoon, William E Culp, Jason R Lees, Kai W Wucherpfennig, David W Scot. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells. Journal of autoimmunity. vol 92. 2019-06-25. PMID:29857928. |
importantly, we showed that these engineered tregs were able to function effectively in the presence of strong tlr-induced inflammatory signals, and that mbp-specific tregs ameliorated eae in myelin oligodendrocyte glycoprotein (mog)-immunized dr15 transgenic mice. |
2019-06-25 |
2023-08-13 |
mouse |
| F Gillard, C Andris, E Lommer. [Extended optic neuropathy with myelin oligodendrocyte glycoprotein antibodies]. Revue medicale de Liege. vol 74. issue 4. 2019-06-25. PMID:30997966. |
later, the detection of mog igg1 antibodies, directed against an oligodendrocyte myelin glycoprotein, made it possible to distinguish pathologies with different clinical and prognostic particularities, then helping the clinician in his diagnostic and therapeutic approach. |
2019-06-25 |
2023-08-13 |
Not clear |
| Cynthia Wang, Ram Narayan, Benjamin Greenber. Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases. Pediatric neurology. vol 86. 2019-06-20. PMID:30077551. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disorders frequently manifest as optic neuritis, transverse myelitis, and acute disseminated encephalomyelitis. |
2019-06-20 |
2023-08-13 |
Not clear |
| Itay Lotan, Judith Brody, Mark Andrew Hellmann, Omer Bialer, Esther Ganelin-Cohen, Natalia Michaeli, Romain Marignier, Hadas Stiebel-Kalis. Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation. Journal of neurology. vol 265. issue 9. 2019-06-19. PMID:29938337. |
optic neuritis (on) is a common clinical manifestation in myelin oligodendrocyte glycoprotein (mog) antibody-associated disease. |
2019-06-19 |
2023-08-13 |
Not clear |
| Azusa Ikeda, Yoshihiro Watanabe, Hikari Kaba, Kimihiko Kaneko, Toshiyuki Takahashi, Saoko Takeshit. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature. Brain & development. vol 41. issue 4. 2019-06-17. PMID:30447856. |
myelin oligodendrocyte glycoprotein antibodies (mog abs) are frequently detected in pediatric acquired demyelinating syndrome (ads), and mog-ab-positive ads differs from multiple sclerosis (ms) and aquaporin-4 (aqp4)-ab-positive neuromyelitis optica spectrum disorder (nmosd) in terms of age distribution, therapeutic response, and prognosis. |
2019-06-17 |
2023-08-13 |
Not clear |
| Michaela Tanja Haindl, Ulrike Köck, Milena Zeitelhofer-Adzemovic, Franz Fazekas, Sonja Hochmeiste. The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis. Glia. vol 67. issue 3. 2019-06-13. PMID:30484905. |
to explore these mechanisms, we investigated the astrocytic reaction in an animal model induced by immunization with myelin oligodendrocyte glycoprotein (mog) in dark agouti (da) rats, which mimics most of the histological features of ms. we correlated the astroglial reaction by immunohistochemistry (ihc) for glial fibrillary acidic protein (gfap) to the remyelination capacity by in situ hybridization for mrna of proteolipid protein (plp), indicative of opcs, over the full course of the disease. |
2019-06-13 |
2023-08-13 |
rat |
| Aleksandar Stojic, Jovana Bojcevski, Sarah K Williams, Carlos Bas-Orth, Stefan Nessler, Christopher Linington, Ricarda Diem, Richard Fairles. Preclinical stress originates in the rat optic nerve head during development of autoimmune optic neuritis. Glia. vol 67. issue 3. 2019-06-13. PMID:30578556. |
since treatment of isolated oligodendrocytes with sera from myelin oligodendrocyte glycoprotein (mog)-immunized animals induced an increase in αb-crystallin expression, as did passive transfer of sera from mog-immunized animals to unimmunized recipients, we propose that the partially permeable blood-brain barrier of the optic nerve head may present an opportunity for blood-borne components such as anti-mog antibodies to come into contact with oligodendrocytes as one of the earliest events in disease development. |
2019-06-13 |
2023-08-13 |
rat |
| Marta Pedreño, Maria Sepúlveda, Thais Armangué, Lidia Sabater, Eugenia Martínez-Hernandez, Georgina Arrambide, Yolanda Blanco, Sara Llufriu, Elena H Martínez-Lapiscina, Patricia Mulero, Nuria Sola-Valls, Raquel Ruiz-García, Mar Tintoré, Josep Dalmau, Francesc Graus, Albert Sai. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease. Multiple sclerosis and related disorders. vol 28. 2019-06-13. PMID:30623863. |
to determine the frequency and relevance of igm, and iga antibodies against myelin oligodendrocyte glycoprotein (mog) in mog-igg-associated disease. |
2019-06-13 |
2023-08-13 |
Not clear |
| Ram N Narayan, Morgan McCreary, Darrel Conger, Cynthia Wang, Benjamin M Greenber. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Multiple sclerosis and related disorders. vol 28. 2019-06-12. PMID:30576847. |
unique characteristics of optical coherence tomography (oct) results and visual acuity testing in myelin oligodendrocyte glycoprotein (mog) antibody positive pediatric patients. |
2019-06-12 |
2023-08-13 |
Not clear |
| Ram N Narayan, Morgan McCreary, Darrel Conger, Cynthia Wang, Benjamin M Greenber. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Multiple sclerosis and related disorders. vol 28. 2019-06-12. PMID:30576847. |
optic nerve involvement in anti-myelin oligodendrocyte glycoprotein antibody associated syndrome (mog ab syndrome) tends to have unique features. |
2019-06-12 |
2023-08-13 |
Not clear |
| Esra Sarigecili, Meltem Direk Cobanogullari, Mustafa Komur, Cetin Okuya. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child. Multiple sclerosis and related disorders. vol 28. 2019-06-12. PMID:30590238. |
myelin oligodendrocyte glycoprotein antibodies (mog) may be used as a biomarker for diagnosis of many demyelinating diseases. |
2019-06-12 |
2023-08-13 |
Not clear |
| Esra Sarigecili, Meltem Direk Cobanogullari, Mustafa Komur, Cetin Okuya. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child. Multiple sclerosis and related disorders. vol 28. 2019-06-12. PMID:30590238. |
we present a child with autoimmune encephalitis in whom antibodies against myelin oligodendrocyte glycoprotein (mog) and n-methyl-d-aspartate receptor (nmdar) were simultaneously detected. |
2019-06-12 |
2023-08-13 |
Not clear |
| Nisha Patro, Aijaz Ahmad Naik, Ishan K Patr. Developmental Changes in Oligodendrocyte Genesis, Myelination, and Associated Behavioral Dysfunction in a Rat Model of Intra-generational Protein Malnutrition. Molecular neurobiology. vol 56. issue 1. 2019-06-11. PMID:29752656. |
late embryonic and early postnatal brains from f1 rat born to protein malnourished mothers were studied through a combination of immunocytochemical and quantitative pcr assay for analyzing the relative expression of platelet-derived growth factor receptor-α (pdgfrα), myelin-associated glycoprotein (mag), proteolipid protein (plp), and myelin oligodendrocyte glycoprotein (mog) to determine oligodendrocyte genesis, differentiation, maturation, and myelination. |
2019-06-11 |
2023-08-13 |
rat |
| Xiaonan Zhong, Yanyu Chang, Sha Tan, Jingqi Wang, Xiaobo Sun, Aimin Wu, Lisheng Peng, Alexander Y Lau, Allan G Kermode, Wei Qi. Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC neurology. vol 19. issue 1. 2019-06-10. PMID:31072329. |
meningoencephalitis has recently been suggested to be a clinical finding typical of myelin oligodendrocyte glycoprotein (mog) encephalomyelitis. |
2019-06-10 |
2023-08-13 |
Not clear |